{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:59:10Z","timestamp":1669309150233},"reference-count":38,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1507\/endocrj.ej12-0267","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T22:57:57Z","timestamp":1354143477000},"page":"215-223","source":"Crossref","is-referenced-by-count":1,"title":["Increased protein kinase A type I\u03b1 regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism"],"prefix":"10.1507","volume":"60","author":[{"given":"Yatsuka","family":"Hibi","sequence":"first","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukushi","family":"Kambe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University, Nagoya 464-8601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya 466-8560, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimio","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikara","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Iwase","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM (1988) Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. <i>N Engl J Med<\/i> 318: 658-662.","DOI":"10.1056\/NEJM198803173181102"},{"key":"2","unstructured":"2. Akerstrom G, Grimelius L (1994) Current controversy in parathyroid operation and reoperation. In: Akerstrom G (ed) Parathyroid pathology. Austin: R.G. Landes Company: 23-41."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Arnold A, Kim HG (1989) Clonal loss of one chromosome 11 in a parathyroid adenoma. <i>J Clin Endocrinol Metab<\/i> 69: 496-499.","DOI":"10.1210\/jcem-69-3-496"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kremer R, Bolivar I, Goltzman D, Hendy GN (1989) Influence of calcium and 1,25-dihydroxycholecalciferonl on proliferation and protooncogene expression in primary cultures of bovine parathyroid cells. <i>Endocrinology<\/i> 125:935-941.","DOI":"10.1210\/endo-125-2-935"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Friedman E, Bale AE, Marx SJ, et al. (1990) Genetic abnormalities in sporadic parathyroid adenomas. <i>J Clin Endocrinol Metab<\/i> 71:293-297.","DOI":"10.1210\/jcem-71-2-293"},{"key":"6","unstructured":"6. Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, et al. (2002) Molecular pathogenesis of primary hyperparathyroidism. <i>J Bone Miner Res<\/i> 17 Suppl 2: N30-36."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114114"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.5.1736"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00396.x"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/ng0897-375"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.8.2960"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.8.2627"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Carling T, Rastad J, Szabo E, Westin G, Akerstrom G (2000) Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. <i>J Clin Endocrinol Metab<\/i> 85:2000-2003.","DOI":"10.1210\/jc.85.5.2000"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.4.1598"},{"key":"15","unstructured":"15. Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, et al. (2000) Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism. <i>J Clin Endocrinol Metab<\/i> 85:4789-4794."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Samander EH, Arnold A (2006) Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas. <i>J Clin Endocrinol Metab<\/i> 91:5019-5021.","DOI":"10.1210\/jc.2006-1543"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.6.878"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Krebs LJ, Shattuck TM, Arnold A (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. <i>J Clin Endocrinol Metab<\/i> 90:5015-5017.","DOI":"10.1210\/jc.2005-0717"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Amieux PS, McKnight GS (2002) The essential role of RI alpha in the maintenance of regulated PKA activity. <i>Ann N Y Acad Sci<\/i> 968:75-95.","DOI":"10.1111\/j.1749-6632.2002.tb04328.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hibi Y, Kambe F, Tominaga Y, Mizuno Y, Kobayashi, et al. (2006) Up-regulation of the gene encoding protein kinase A type I alpha regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure. <i>J Clin Endocrinol Metab<\/i> 91:563-568.","DOI":"10.1210\/jc.2005-2155"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, et al. (1996) Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. <i>World J Surg<\/i> 20:744-750; discussion 750-752.","DOI":"10.1007\/s002689900113"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800229"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Costa-Guda J, Tokura T, Roth SI, Arnold A (2007) Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas. <i>BMC Endocr Disord<\/i> 7: 8.","DOI":"10.1186\/1472-6823-7-8"},{"key":"24","unstructured":"24. Cho YS, Cho-Chung YS (2003) Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy. <i>Clin Cancer Res<\/i> 9:1171-1178."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bossis I, Stratakis CA (2004) Minireview: PRKAR1A: normal and abnormal functions. <i>Endocrinology<\/i> 145:5452-5458.","DOI":"10.1210\/en.2004-0900"},{"key":"26","unstructured":"26. Tortora G, Pepe S, Bianco C, Baldassarre G, Budillon A, et al. (1994) The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. <i>Oncogene<\/i> 9:3233-3240."},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910590521"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cho-Chung YS (2004) Antisense protein kinase A RI alpha-induced tumor reversion: portrait of a microarray. <i>Biochim Biophys Acta<\/i> 1697:71-79.","DOI":"10.1016\/j.bbapap.2003.11.014"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, et al. (1998) Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. <i>Mol Cell Biol<\/i> 18:3509-3517.","DOI":"10.1128\/MCB.18.6.3509"},{"key":"30","unstructured":"30. Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, et al. (2002) Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. <i>Clin Cancer Res<\/i> 8:607-614."},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1021\/bi981402a"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1038\/79238"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, et al. (2000) Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. <i>Hum Mol Genet<\/i> 9:3037-3046.","DOI":"10.1093\/hmg\/9.20.3037"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198507000-00007"},{"key":"35","unstructured":"35. Stratakis CA (2000) Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. <i>Front Biosci<\/i> 5:D353-366."},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.7.3993"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1038\/382622a0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Arnold BM, Kovacs K, Horvath E, Murray TM, Higgins HP (1974) Functioning oxyphil cell adenoma of the parathyroid gland: evidence for parathyroid secretory activity of oxyphil cells. <i>J Clin Endocrinol Metab<\/i> 38:458-462.","DOI":"10.1210\/jcem-38-3-458"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/2\/60_EJ12-0267\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:33:19Z","timestamp":1618295599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/2\/60_EJ12-0267\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej12-0267","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}